Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Indo US Bio-Tech's share price for the quarter that ended in Mar. 2026 was ₹98.21. Indo US Bio-Tech's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 20 Mil. Therefore, Indo US Bio-Tech's market cap for the quarter that ended in Mar. 2026 was ₹1,969 Mil.
Indo US Bio-Tech's quarterly market cap
declined
from Sep. 2025 (₹2,660 Mil) to Dec. 2025 (₹2,438 Mil) and
declined
from Dec. 2025 (₹2,438 Mil) to Mar. 2026 (₹1,969 Mil).
Indo US Bio-Tech's annual market cap
increased
from Mar. 2024 (₹0 Mil) to Mar. 2025 (₹2,987 Mil) but then
declined
from Mar. 2025 (₹2,987 Mil) to Mar. 2026 (₹1,969 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Indo US Bio-Tech's Enterprise Value for Today is ₹2,075 Mil.
Indo US Bio-Tech (NSE:INDOUS) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Indo US Bio-Tech Market Cap Related Terms
Indo US Bio-Tech Market Cap Historical Data
* Premium members only.
The historical data trend for Indo US Bio-Tech's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:INDOUS vs CTVA, CF, MOS: Market Cap Comparison
For the Agricultural Inputs subindustry, Indo US Bio-Tech's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Indo US Bio-Tech Market Cap vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Indo US Bio-Tech's Market Cap distribution charts can be found below:
* The bar in red indicates where Indo US Bio-Tech's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Indo US Bio-Tech's Market Cap for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Indo US Bio-Tech (NSE:INDOUS) has a Market Cap of ₹1,774 Mil as of Jul. 03, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Indo US Bio-Tech and its competitors. According to the industry distribution chart, Indo US Bio-Tech ranks #210 out of 265 companies in the Agriculture industry, placing it in the top 79.2%.
Is Indo US Bio-Tech's Market Cap too high?
Indo US Bio-Tech's current Market Cap is ₹1,774 Mil. Based on the distribution chart, Indo US Bio-Tech ranks #210 out of 265 companies in the Agriculture industry, which is in the bottom quartile relative to peers. Overall, Indo US Bio-Tech has a GF Score™ of 63/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Indo US Bio-Tech's Market Cap compare to CTVA and CF?
According to the Agriculture industry distribution chart, Indo US Bio-Tech ranks #210 out of 265 companies for Market Cap. This places Indo US Bio-Tech in the lower half of its industry. The industry median Market Cap is 197.91. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for an Agriculture company?
The median Market Cap among Agriculture companies is 197.91, based on 265 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Indo US Bio-Tech and its competitors. For the Agriculture industry, the median Market Cap is 197.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Indo US Bio-Tech's current Market Cap is ₹1,774 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indo US Bio-Tech stock overvalued right now?
Based on GuruFocus' analysis, Indo US Bio-Tech (NSE:INDOUS) is currently considered Possible Value Trap. The stock's GF Value™ is ₹198.21, compared to a current price of ₹88.30 — trading 55.5% below its estimated fair value. The current Market Cap is ₹1,774 Mil. Indo US Bio-Tech's overall GF Score™ is 63/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Indo US Bio-Tech (NSE:INDOUS), the current Market Cap is ₹1,774 Mil as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Indo US Bio-Tech (NSE:INDOUS) Overvalued in 2026?
Based on GuruFocus' analysis, Indo US Bio-Tech stock appears to be undervalued.
The current stock price of ₹88.30 is trading 55.5% below its estimated GF Value™ of ₹198.21.
GuruFocus considers Indo US Bio-Tech to be Possible Value Trap.
Key valuation signals for NSE:INDOUS:
Market Cap: ₹1,774 Mil
GF Value™: ₹198.21 vs. price of ₹88.30 (55.5% below fair value)
No single metric tells the full story. See the NSE:INDOUS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Indo US Bio-Tech Ltd is a specialized agriculture seed company. It is involved in crop research and development through breeding, production of seeds, processing, packing, and marketing of high-performing hybrid and open-pollinated varieties of crops. The company's product portfolio includes a diversified variety of agricultural seeds, namely vegetable seeds, oil seeds, pulses seeds, cereals seeds, spices seeds used in cultivating all kinds of vegetables, pulses, crops like tomato, okra, brinjal, onion, bit root, cucumber, bottle gourd, groundnut, mustard, bajra, wheat, etc.
63GF Score
Get the complete analysis for NSE:INDOUS
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:INDOUS has been successfully added to your 
